+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I



Serum lactate dehydrogenase isoenzyme 1 and relapse in patients with nonseminomatous testicular germ cell tumors clinical stage I



Acta Oncologica 40(4): 536-540



Serum lactate dehydrogenase isoenzyme 1 catalytic concentration (S-LD-1) was measured at the time of orchiectomy in 104 patients with nonseminomatous testicular germ cell tumors (NSTGCT) clinical stage I who participated in a randomized study comparing surveillance after orchiectomy (group I) and radiotherapy (group II). For 68 patients, S-LD-1 was measured in a serum sample before or on the day of the orchiectomy. Twenty-seven patients (40%) had elevated S-LD-1; median 102 U/L (range 41-335). For the remaining 36 patients. S-LD-1 was measured in a serum sample after orchiectomy: 8 of these patients (22%) had elevated S-LD-1. S-LD-1 was normalized shortly after surgery in most patients with a preorchiectomy elevated S-LD-1. Fifteen of the 68 patients relapsed: 9 out of 27 with an elevated S-LD-1 and 6 out of 41 patients with normal S-LD-1 (p = 0.13, Fisher's exact test). In group 1, those with a preoperatively elevated S-LD-1 had a lower 8-years' relapse-free survival than those with a normal S-LD-1 (40% vs. 80%, p = 0.003, log-rank test). The role of S-LD-1 in the staging, prognostication and monitoring of patients with NSGCT clinical stage I should be further explored in a large, prospective study.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011348609

Download citation: RISBibTeXText

PMID: 11504315

DOI: 10.1080/02841860118236


Related references

Serum lactate dehydrogenase isoenzyme 1: An early indicator of relapse in patients with testicular germ cell tumors. Acta Oncologica 34(7): 925-929, 1995

Risk factors for relapse in patients with clinical stage I testicular nonseminomatous germ cell tumors. Medical Oncology 30(1): 494, 2013

Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors. Clinical Chemistry and Laboratory Medicine 39(1): 38-44, 2001

Lactate dehydrogenase and its isoenzyme, LDH-1, in serum are markers of testicular germ cell tumors. Clinical Chemistry 30(2): 340-341, 1984

Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. Journal of Clinical Oncology 21(8): 1505-1512, 2003

Serum lactate dehydrogenase isoenzyme 1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arm of chromosome 12 in the tumor. Molecular & General Genetics 235(1): 140-146, 1992

Elevated lactate dehydrogenase isoenzyme 1 as a tumor marker in patients with germ cell cell testicular tumors. Australian & New Zealand Journal of Surgery 58(9): 737-742, 1988

Is retroperitoneal lymph node dissection alone optimal or sufficient therapy for clinical stage I nonseminomatous germ cell testicular tumors at high risk for relapse?. Journal of Urology 159(5 SUPPL ): 49, 1998

Serum lactate dehydrogenase isoenzyme 1 as a predictor of tumour-associated death in patients with testicular germ cell tumours. Andrologia 29(3): 137-140, 1997

It is rational to measure serum lactate dehydrogenase isoenzyme-1 activity in patients with testicular germ cell tumours. European Journal of Clinical Chemistry and Clinical Biochemistry 35(12): 943, 1998

Correcting for contamination from hemolysis in measurements of lactate dehydrogenase isoenzyme 1 in serum from patients with testicular germ cell. Clinical Chemistry 39(10): 2199-2199, 1993

Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. World Journal of Urology 33(9): 1351-1357, 2016

Lactate dehydrogenase isoenzyme 1 in testicular germ cell tumors. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 123: 85-92, 1991

The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors. Seminars in Urology 11(2): 92-98, 1993

Lactate dehydrogenase isoenzyme 1 is the most important LD isoenzyme in patients with testicular germ cell tumor. Acta Oncologica 39(4): 509-517, 2000